We are live on ! Find out more
CASM

CAS Medical Systems
CASM

Delisted

CASM was delisted on the 18th of April, 2019.

19 hedge funds and large institutions have $4.96M invested in CAS Medical Systems in 2017 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

12% more funds holding

Funds holding: 17 → 19 (+2)

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

2.61% less ownership

Funds ownership: 25.44% → 22.83% (-2.6%)

84% less capital inflows, than outflows

Capital inflows: $133K | Capital outflows: $845K

Holders
19
Holders Change
+2
Holders Change %
+11.76%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
3
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

CASM Hedge Fund Activity: Q4 2017 in Review

19 of the 4,421 institutional investors tracked by Wall St. Rank reported a position in CAS Medical Systems (CASM) for Q4 2017, worth a combined $4.96M — down 25% from $6.61M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new CASM positions and 3 closed out — a net gain of 2 holders — while 3 added to existing stakes and 3 trimmed.

The largest buyer was Acuta Capital Partners, adding an estimated $48.8K. The largest seller was Stonepine Capital Management, exiting entirely with an estimated $748K sold.

  • 19 institutional investors held CAS Medical Systems (CASM) as of Q4 2017, up from 17 in Q3 2017.
  • Funds reported $4.96M of CAS Medical Systems stock for Q4 2017, down 25% quarter-over-quarter.
  • 5 funds opened new CAS Medical Systems positions in Q4 2017 and 3 closed out, a net change of +2 holders.
  • The largest CAS Medical Systems buyer in Q4 2017 was Acuta Capital Partners, an estimated $48.8K added.
  • The largest CAS Medical Systems seller in Q4 2017 was Stonepine Capital Management, an estimated $748K sold.

Based on aggregated 13F filings for Q4 2017.